PHKG2 and non-small cell lung carcinoma: The above results indicate that overexpression of PHKG2 could not induce significant mitochondrial dysfunction in NSCLC cells but could promote radiotherapy-induced mitochondrial dysfunction and thus enhance their radiosensitivity.